← Leaderboards
Kyle Dyson
University Of Florida
$207,060
Attributed
$207,060
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50.5K · FY2017–21$100K$75K$50K$25K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$207,060 · 1
By mechanism
F30$207,060 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Margaret O James$2,557,334
- Xingming Deng$11,809,682
- Connor Patrick Francis$233,985
- Stephen Patrick Hunger$7,938,370
- Joel Schiffenbauer$526,576
Others in their field
Other Emerging Leaders on “Cognitive Deficits”
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Alberto Rafael Ramos · University Of Miami School Of Medicine$11,170,423
- Jennifer Cohen Price · University Of California, San Francisco$9,197,178
- Fabio Ferrarelli · University Of Pittsburgh At Pittsburgh$8,128,613
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$7,430,223
- Tristan Shuman · Icahn School Of Medicine At Mount Sinai$6,845,931
Research focus
Cognitive DeficitsCollectionChildhood Cancer MortalityClonal EvolutionChildhood Malignant Brain TumorAnimalsAntigensAffectAdoptive TransferClinical TrialsChildhood Brain NeoplasmAutologousBaseBrainBrain NeoplasmsCancer EtiologyCancer TherapyCategoriesCellsCerebellumCessation Of LifeChemotherapyChildCoupled
Grant awards (5)
Immunologic Targeting of Developmentally-Regulated Antigens for the Treatment of High-Risk Medulloblastoma$28,314
F30 · FY2021 · CA · contact PI
Immunologic Targeting of Developmentally-Regulated Antigens for the Treatment of High-Risk Medulloblastoma$50,520
F30 · FY2020 · CA · contact PI
Immunologic Targeting of Developmentally-Regulated Antigens for the Treatment of High-Risk Medulloblastoma$50,016
F30 · FY2019 · CA · contact PI
Immunologic Targeting of Developmentally-Regulated Antigens for the Treatment of High-Risk Medulloblastoma$40,126
F30 · FY2018 · CA · contact PI
Immunologic Targeting of Developmentally-Regulated Antigens for the Treatment of High-Risk Medulloblastoma$38,084
F30 · FY2017 · CA · contact PI